Brca1-deficient pancreatic ductal adenocarcinoma cells are hyper-sensitive to DNA-damaging agents

被引：0
作者：
Hirsch, S. [1 ,2 ]
Shakya, R. [2 ]
Szabolcs, M. [2 ]
Hartmann, J-T [1 ]
Ludwig, T. [2 ]
机构：
[1] Univ Klinikum Schleswig Holstein, Kiel, Germany
[2] Columbia Univ, Inst Canc Genet, Dept Pathol & Cell Biol, New York, NY USA
来源：
ONKOLOGIE | 2011年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [21] DYNLL1 INHIBITS DNA END RESECTION IN BRCA1-DEFICIENT CELLS AND REGULATES PARP INHIBITOR SENSITIVITY
    He, Yizhou Joseph
    Meghani, Khyati
    Caron, Marie-Christine
    Yang, Chunyu
    Ronato, Daryl A.
    Bian, Jie
    Sharma, Anchal
    Miller, Jessica
    Joshi, Niraj
    Detappe, Alexandre
    Doench, John G.
    Legube, Gaelle
    Root, David E.
    D'Andrea, Alan D.
    Drane, Pascal
    De, Subhojyoti
    Konstantinopoulos, Panagiotis
    Masson, Jean-Yves
    Chowdhury, Dipanjan
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 90 - 90
  • [22] CDK1 promotes nascent DNA synthesis and induces resistance of cancer cells to DNA-damaging therapeutic agents
    Liao, Hongwei
    Ji, Fang
    Geng, Xinwei
    Xing, Meichun
    Li, Wen
    Chen, Zhihua
    Shen, Huahao
    Ying, Songmin
    ONCOTARGET, 2017, 8 (53) : 90662 - 90673
  • [23] Novel ATM/ATR pathway inhibitors sensitize p53-deficient cells to DNA-damaging agents in vitro and in vivo
    Kawasumi, M.
    Sloan, H.
    Bradner, J.
    Nghiem, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S30 - S30
  • [24] EFFECT OF ERCC-1 OVEREXPRESSION ON SENSITIVITY OF CHINESE-HAMSTER OVARY CELLS TO DNA-DAMAGING AGENTS
    BRAMSON, J
    PANASCI, LC
    CANCER RESEARCH, 1993, 53 (14) : 3237 - 3240
  • [25] Suppression of DNA Polymerase β Activity is Synthetically Lethal in BRCA1-Deficient Cells (vol 16, pg 1339, 2021)
    Yuhas, Shelby C.
    Mishra, Alok
    DeWeese, Theodore L.
    Greenberg, Marc M.
    ACS CHEMICAL BIOLOGY, 2022, 17 (02) : 492 - 492
  • [26] Histone chaperone ASF1 acts with RIF1 to promote DNA end joining in BRCA1-deficient cells
    Tang, Mengfan
    Chen, Zhen
    Wang, Chao
    Feng, Xu
    Lee, Namsoo
    Huang, Min
    Zhang, Huimin
    Li, Siting
    Xiong, Yun
    Chen, Junjie
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (06)
  • [27] Abrogation of the G(2) Checkpoint by Inhibition of Wee-1 Kinase Results in Sensitization of p53-Deficient Tumor Cells to DNA-Damaging Agents
    Leijen, Suzanne
    Beijnen, Jos H.
    Schellens, Jan H. M.
    CURRENT CLINICAL PHARMACOLOGY, 2010, 5 (03): : 186 - 191
  • [28] Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
    Zhu, Yinghua
    Liu, Yujie
    Zhang, Chao
    Chu, Junjun
    Wu, Yanqing
    Li, Yudong
    Liu, Jieqiong
    Li, Qian
    Li, Shunying
    Shi, Qianfeng
    Jin, Liang
    Zhao, Jianli
    Yin, Dong
    Efroni, Sol
    Su, Fengxi
    Yao, Herui
    Song, Erwei
    Liu, Qiang
    NATURE COMMUNICATIONS, 2018, 9
  • [29] Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
    Yinghua Zhu
    Yujie Liu
    Chao Zhang
    Junjun Chu
    Yanqing Wu
    Yudong Li
    Jieqiong Liu
    Qian Li
    Shunying Li
    Qianfeng Shi
    Liang Jin
    Jianli Zhao
    Dong Yin
    Sol Efroni
    Fengxi Su
    Herui Yao
    Erwei Song
    Qiang Liu
    Nature Communications, 9
  • [30] A chemical genetic screen reveals novel ATR/ATM pathway inhibitors that sensitize p53-deficient cells to DNA-damaging agents
    Kawasumi, M.
    Sloan, H.
    Bradner, J.
    Nghiem, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S26 - S26
12345